In the present study, we tested the hypothesis that elevated leptin plays a pathogenic role in SLE disease progression and promotes the development of autoimmune-associated hypertension and renal injury in the NZBWF1 mouse model of SLE, which has elevated leptin levels. This evidence concerns the gene LEP and systemic lupus erythematosus.